Ethanol Impurity Analysis Using the Agilent Cary 3500 Flexible UV-Vis Spectrophotometer

Significance of the topic

Ethanol is widely used in pharmaceutical manufacturing as a solvent, disinfectant and preservative. Regulatory pharmacopeias (USP, EP, JP) require sensitive ultraviolet (UV‑Vis) absorption testing to detect low‑level impurities in ethanol because even trace contaminants can affect drug safety, stability and efficacy. Using extended optical path lengths (e.g., 50 mm) increases sensitivity for weak UV absorbers and is therefore essential for compliance testing and routine quality control (QC).

Objectives and study overview

This application note demonstrates a practical workflow for pharmacopeia‑compliant ethanol impurity testing using the Agilent Cary 3500 Flexible UV‑Vis spectrophotometer combined with Cary UV Workstation software and a long‑path‑length (50 mm) cell holder. Two commercially available undenatured ethanol samples (100% and 96%) were evaluated against pharmacopeial absorbance acceptance limits to illustrate instrument capability, software automation and reporting for routine QC.

Methodology

Samples and preparation:

• Blank: Milli‑Q water in a 50 mm rectangular quartz cuvette (17 mL).
• Samples: Two undenatured ethanol products measured in capped 50 mm quartz cuvettes to minimize evaporation.

Acceptance criteria (pharmacopeias):

• 240 nm: absorbance ≤ 0.40
• 250–260 nm: absorbance ≤ 0.30
• 270–340 nm: absorbance ≤ 0.10

Instrumental parameters:

• Instrument: Agilent Cary 3500 Flexible UV‑Vis spectrophotometer with variable long‑path‑length cell holder set to 50 mm.
• Software: Agilent Cary UV Workstation with end‑of‑sequence analysis and customizable calculator.
• Wavelength range: 235–340 nm
• Spectral bandwidth: 2.00 nm
• Data interval: 1.00 nm
• Signal averaging time: 0.1 s
• Blank: water

Used instrumentation

• Agilent Cary 3500 Flexible UV‑Vis spectrophotometer with xenon flash lamp (10‑year replacement warranty).
• Variable path‑length cell holder (toolless switching among 20, 40, 50 and 100 mm; supports rectangular and cylindrical cuvettes).
• Agilent Cary UV Workstation software (end‑of‑sequence analysis, customizable calculations, method saving).
• 50 mm rectangular quartz cuvettes (Agilent part number 6610016100).

Results and discussion

Spectra were collected across 235–340 nm and automatically analyzed with the workstation software to extract maximum absorbance values within the pharmacopeial wavelength bands.

• 100% undenatured ethanol: the spectrum was a smooth, monotonically descending curve with no pronounced peaks or shoulders, suggesting only trace impurities rather than gross contamination. It met two of the three acceptance limits but exceeded the threshold at 240 nm (absorbance > 0.40), therefore failing the overall pharmacopeial criterion.
• 96% undenatured ethanol: this sample met all three numerical acceptance limits and thus passed the pharmacopeial test. The spectrum displayed a small bump between ~260–290 nm, indicating the presence of absorptive species, but their intensities remained below regulatory thresholds.

These outcomes illustrate two important points: first, extended path length (50 mm) reliably enhances detection sensitivity for weak absorbers; second, spectrum shape (smooth descending baseline versus localized bumps) provides qualitative insight about impurity character (trace broad absorbers versus discrete chromophores), complementary to the numeric acceptance criteria.

Benefits and practical applications

• Regulatory compliance: The method supports multipharmacopeia testing (USP, EP, JP) as it uses the specified path length and wavelength bands and can automate acceptance checks.
• Improved sensitivity: Long‑path‑length cells increase absorbance signals for low‑level impurities without chemical derivatization or concentration steps.
• Workflow efficiency: Cary UV Workstation automates spectral acquisition, end‑of‑sequence analysis and report generation (PDF/CSV), and enables method saving to standardize routine QC.
• Data integrity and traceability: Optional integration with Agilent OpenLab provides administrative controls, audit trails and features to help satisfy FDA 21 CFR Part 11 and EU Annex 11 requirements.
• Operational convenience and sustainability: The variable, toolless holder enables reproducible path‑length changes, and the xenon flash lamp reduces warm‑up time and frequency/cost of lamp replacements (10‑year warranty). The instrument has also been independently recognized for sustainability.

Future trends and potential applications

Anticipated developments and opportunities for ethanol impurity testing and UV‑Vis QC workflows include:

• Inline and at‑line monitoring: coupling long‑path optics and flow cells for continuous production monitoring and faster release testing.
• Advanced data analytics: application of multivariate methods and machine learning to spectral fingerprints to classify impurity sources, predict out‑of‑spec causes, and reduce false positives from spectral baselines.
• Method harmonization and digital workflows: broader adoption of shared, validated digital methods and instrument qualification routines across global labs to streamline regulatory acceptance.
• Green analytical chemistry: minimizing solvent use and instrument energy footprint by leveraging long‑lived light sources, efficient data acquisition and automated workflows.
• Expanded detector and accessory technologies: integration with higher sensitivity detectors or complementary spectroscopic techniques (e.g., LC‑UV hyphenation) for orthogonal impurity identification when needed.

Conclusion

The Agilent Cary 3500 Flexible UV‑Vis spectrophotometer combined with a 50 mm variable path‑length holder and Cary UV Workstation software provides a practical, regulatory‑aware solution for pharmacopeia‑compliant ethanol impurity testing. The system enhances sensitivity for low‑level absorbers, streamlines routine QC through automated analysis and reporting, and supports data integrity requirements. In the demonstrated test, a 96% ethanol product passed all pharmacopeial absorbance criteria, while a 100% ethanol product exceeded the 240 nm limit, highlighting the method's ability to detect trace absorbances relevant to pharmaceutical quality control.

Reference

1. Agilent Technologies. Effortlessly Change Path Length to Enhance Photometric Performance; Technical overview 5994‑5781EN, 2023.
2. Pure Chemistry. Ethanol in Pharmaceutical Manufacturing (99.9% Purity); industry overview.
3. United States Pharmacopeia. Alcohol. USP–NF Monographs; USP reference (Alcohol), USP–NF.
4. European Directorate for the Quality of Medicines & HealthCare. Ethanol 96%. European Pharmacopoeia, 12th ed.; monograph 1317, 2025.
5. Ministry of Health, Labour and Welfare. Ethanol. Japanese Pharmacopoeia, 18th ed.; 2021.
6. Agilent Technologies. Data Integrity Options for GMP Facilities; flyer 5994‑0740EN, 2022.
7. Agilent Technologies. Pharmaceutical Analysis Using UV‑Vis: Compliance with USP Chapter <857> and Ph. Eur. Chapter 2.2.25; Application note 5994‑1188EN, 2020.